ABSTRACT
Objective@#To investigate the expression level of IL-32 in peripheral blood mononuclear cells (PBMCs) and its correlation with serum biochemical indices of liver function test and HBV DNA load in chronic hepatitis B (CHB) patients with PEG IFN-α-2a treated.@*Methods@#Thirty CHB patients with PEG IFN-α-2a treated (CHB group) and thirty normal health donors (health group) were enrolled in the study. Total RNA in PBMCs was extracted by using TRIzol. Than IL-32 mRNA level was assayed by using Real-time PCR. The correlation between IL-32 and ALT, AST, TBIL, HBV DNA load was analyzed using pearson′s correlation analysis, respectively.@*Results@#IL-32 expression level in CHB group was significantly lower than that of health group. Moreover, the difference between them was statistically significant (P=0.000). IL-32 level was positively correlated with serum ALT and AST, respectively (P=0.035, P=0.032), but was not correlated with ALB and HBV DNA load (P=0.856, P=0.580).@*Conclusions@#IL-32 expression level was decreased in CHB patients with PEG IFN-α-2a Treated and was associated with the severity of inflammation.
ABSTRACT
Objective:To investigate interleukin-32 (IL-32)(rs28372698A/T,rs12934561C/T and rs11861531C/T) genetic susceptibility in patients with multiple sclerosis(MS)by case-control study,which provides a theoretical foundation for high-risk population with MS.Methods:A total 580 MS patients and 650 healthy controls were included in this study,polymerase chain reaction-single base extension (PCR-SEB) was used to test DNA sequencing,and serum levels of IL-32 were determined by enzyme-linked im-munosorbent assay.Results:The genotype and allele frequency of IL-32 (rs28372698A/T) had significantly differences compared with healthy controls (P=0.007,P=0.033),however,there were no statistical differences in rs12934561C/T and rs11861531C/T between the two groups (P>0.05).T-T-T haploid genotype in patients with MS was higher than control groups(P=0.012),and T-T-T haploid genotype was associated with increased risk of MS(OR=1.968,95% CI:1.968-1.352).Serum levels of IL-32 in patients with MS was increased compared with control groups[(399.08 ± 156.85)pg/ml vs (239.99 ± 88.35)pg/ml,P= 0.001].The serum IL-32 concentrations in MS patients with AT and TT genotype were higher compared with MS patient with AA genotype[(465.53±172.40) pg/ml vs(295.86±103.96)pg/ml,P<0.01;(491.15±133.65)pg/ml vs(295.86±103.96)pg/ml,P<0.01].Conclusion:Our study found that an association between IL-32(rs28372698) gene polymorphism and MS,and serum levels of IL-32 were influenced by IL-32 gene polymorphism in patients with MS,suggesting a theoretical basis for individualized diagnosis and treatment of MS patients.
ABSTRACT
Objective To investigate the concentration of interleukin-32 (IL-32) in serum,and the expression of IL-32 mRNA in placenta,subcutaneous fat and great epiploon adipose tissue,and explore the relationship between IL-32 and gestational diabetes mellitus (GDM).Methods The concentrations of serum IL-32 in 42 GDM (GDM group) and 38 non-GDM (control group) pregnant women were examined by enzyme linked immunosorbent assay (ELISA).The level of the IL-32mRNA in the placenta,subcutaneous fat and great epiploon adipose tissue was examined by quantitative realtime reverse-transcription polymerase chain reaction (RT-qPCR).The expression levels of IL-32 protein in the placenta and umbilical cord were measured by immunohistochemical staining (IHC) and analyzed by ImagePro Plus 9.0.Results The serum level of IL-32 in the GDM group was significantly higher than that in the control group [(129.3 ± 5.78) pg/mL vs.(105.6 ± 8.61) pg/mL,P＜0.05].The level of IL-32 mRNA was increased 1.32 and 1.66 fold in the placenta (P＜0.05) and the great epiploon adipose tissue (P＜0.05) from GDM women,compared with that from control group.No significant difference was found in the levels of IL-32mRNA in the subcutaneous adipose tissue between the two groups [(3.78 ± 0.53) vs.(3.61 ± 0.35),P＞0.05].The expression of IL-32 in the placenta from GDM group was 1.27 times higher than that from control group (P ＜0.05).The IL-32 in the umbilical artery and umbilical vein of GDM group increased by 1.30 and 1.32 (P＜0.05).But there was no significant difference of IL-32 expression in the umbilical interstitial between the two groups.Conclusions Overexpression of IL-32 in the serum and tissue may be involved in the pathogenesis of GDM.
ABSTRACT
The induction of interleukin (IL)-32 in bone marrow (BM) inflammation is crucial in graft versus host disease (GvHD) that is a common side effect of allogeneic BM transplantation. Clinical trials on α-1 antitrypsin (AAT) in patients with GvHD are based on the preliminary human and mouse studies on AAT reducing the severity of GvHD. Proteinase 3 (PR3) is an IL-32-binding protein that was isolated from human urine. IL-32 primarily induces inflammatory cytokines in myeloid cells, probably due to PR3 expression on the membrane of the myeloid lineage cells. The inhibitory activity of AAT on serine proteinases may explain the anti-inflammatory effect of AAT on GvHD. However, the anti-inflammatory activity of AAT on BM cells remains unclear. Mouse BM cells were treated with IL-32γ and different inflammatory stimuli to investigate the anti-inflammatory activity of AAT. Recombinant AAT-Fc fusion protein inhibited IL-32γ-induced IL-6 expression in BM cells, but failed to suppress that induced by other stimuli. In addition, the binding of IL-32γ to PR3 was abrogated by AAT-Fc. The data suggest that the specific anti-inflammatory effect of AAT in mouse BM cells is due to the blocking of IL-32 binding to membrane PR3.
Subject(s)
Animals , Humans , Mice , Bone Marrow Cells , Bone Marrow , Cytokines , Graft vs Host Disease , Inflammation , Interleukin-6 , Interleukins , Membranes , Myeloblastin , Myeloid Cells , Serine ProteasesABSTRACT
Objective To investigate the correlation between the expression of IL -17,18,32 as well as the lung adenocarcinoma antigen KL -6 and the severity of patients with acute exacerbations of chronic obstructive pulmonary disease (AECOPD).Methods Totally 120 AECOPD patients treated in our hospital (Zhejiang Rongjun Hospital) form Jan 2014 to Jan 2016 were selected.Among them,the condition of 50 cases got controlled after treatment(group A),while other 70 cases did not get controlled(group B).At the same time,26 healthy people were selected as control group.The expression levels of IL -17,18,32 and KL -6 in the blood of there groups were detected by ELISA.Results The IL -17,18,32,KL -6 levels of group A were (49.07 ±17.22)pg/mL,(156.38 ±24.41)pg/mL, (11.63 ±4.05)pg/mL,(106.62 ±13.74)pg/mL,which were significantly higher than those of the control group [(32.32 ±3.04)pg/mL,(134.83 ±18.92)pg/mL,(9.26 ±3.35)pg/mL,(65.24 ±15.51 )pg/mL,t =4.905, 3.926,3.561,11.916,all P <0.05].The IL -17,18,32,KL -6 levels of group B were (92.68 ±13.25)pg/mL, (357.44 ±26.35)pg/mL,(50.10 ±9.88)pg/mL,(285.64 ±25.40)pg/mL,which were significantly higher than those of group A,the differences were statistically significant between the two groups (t =15.674,42.479,25.995, 45.293,all P <0.05 ).Conclusion The expression levels of IL -17,18,32 and lung adenocarcinoma antigen KL -6 are elevated with the increased severity of AECOPD patients.Therefore,the expression levels of these four indicators can be used to evaluate the severity of AECOPD patients.
ABSTRACT
Objective To explore changes of levels of interferon‐γ(IFN‐γ) ,interleukin‐32(IL‐32) and interleukin‐6(IL‐6) in pe‐ripheral blood and the correlation between peripheral IFN‐γ,IL‐32 ,IL‐6 and liver function level and hepatitis B virus(HBV) DNA load in HBV carriers .Methods Sixty HBV carriers ,including 39 cases of chronic HBV carriers and 21 cases of inactive hepatitis B surface antigen(HBsAg) carriers ,and 50 healthy individuals were collected .Serum levels of IFN‐γ,IL‐32 and IL‐6 ,the amount of HBV DNA and liver function were detected ,and clinical correlations were analysed .Results Compared with the control group ,ser‐um levels of IFN‐γ,IL‐32 and IL‐6 of chronic HBV carriers and inactive HBsAg carriers were significantly increased (P0 .05) .There was positive correlation between IL‐32 level and ALT level (r=0 .32 ,P<0 .05) ,and negative correla‐tion between IL‐32 level and ALB level(r= -0 .27 ,P<0 .05) .Conclusion IFN‐γ,IL‐32 and IL‐6 may play important roles in chro‐nic HBV infection ,the levels of IFN‐γ,IL‐32 and IL‐6 could be used as important indicators to assess the severity of inflammation in HBV carriers .
ABSTRACT
Objective To study the changes in interleukin-32 (IL-32) in rats with Klebsiella bacillus pneumonia and approach its significance. Methods Seventy-two Sprague-Dawley(SD)rats were divide into control group,model group and experimental group by the method of random digits table,then the experimental group was subdivided into 4 hours and 1,3 and 5 days experimental subgroups(each n=6). The rat model of Klebsiella bacillus pneumonia was established by injection of 0.3 mL Klebsiella bacterial suspension into the trachea. Before the establishment of the model in the experimental group,IL-32 inhibitory agent,protease activated receptor-2(PAR2) was injected into the abdominal cavity. After model establishment,at different time points,blood was collected via tail vein to observe the changes in serum levels of IL-32,tumor necrosis factor-α(TNF-α),IL-6 and IL-8 in all the groups. The lungs were removed and stained with hematoxylin-eosin(HE)method to investigate the histopathological changes of the lung tissues under the light microscope. Results Compared to the control group, with the prolongation of time the levels of IL-32,TNF-α,IL-8 and IL-6 were increased gradually in the model group,and reached their peaks at 3 days〔IL-32(ng/L):84.40±28.24 vs. 18.57±3.86,t=5.544,P=0.002;TNF-α(ng/L):79.27±14.64 vs. 17.82±3.86, t=9.994, P=0.000;IL-8(ng/L):55.85±10.90 vs. 16.66±3.76,t=8.544, P=0.000;IL-6(ng/L):56.65±2.57 vs. 28.48±2.11,t=19.693,P=0.000〕;PAR2 could inhibit above indexes significantly,there was statistical difference at 3 days compared with the model group〔IL-32(ng/L):54.13±6.68 vs. 84.40±28.24,t=2.560,P=0.046;TNF-α(ng/L):49.12±3.56 vs. 79.27±14.64,t=4.901,P=0.003;IL-8 (ng/L):22.95±2.52 vs. 55.85±10.90,t=7.204,P=0.000;IL-6(ng/L):36.49±2.63 vs. 56.65±2.57,t=13.443, P=0.000〕. Under the light microscope,the inflammatory changes in the lung tissue in experimental group were milder than those in the model group. Conclusion As a pro-inflammatory cytokine,IL-32 can induce the production of TNF-α,IL-6 and IL-8,and the inhibition of IL-32 production may play a role in suppression of the development of Klebsiella bacillus pneumonia.
ABSTRACT
Interleukin-32 is a newly descovered cytokine. In vivo and in vitro studies show that it inhibits the proliferation and induces apoptosis of colon cancer and melanoma by inhibiting NF-κB and signaling and transcription activated factor 3 pathways.In addition,IL-32 suppresses tumor growth in different ways in chronic myelogenous leukemia,sarcoma and prostate cancer.